Your browser doesn't support javascript.
loading
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.
Caserta, Carolina; Nucera, Silvia; Barcella, Matteo; Fazio, Grazia; Naldini, Matteo Maria; Pagani, Riccardo; Pavesi, Francesca; Desantis, Giacomo; Zonari, Erika; D'Angiò, Mariella; Capasso, Paola; Lombardo, Angelo; Merelli, Ivan; Spinelli, Orietta; Rambaldi, Alessandro; Ciceri, Fabio; Silvestri, Daniela; Valsecchi, Maria Grazia; Biondi, Andrea; Cazzaniga, Giovanni; Gentner, Bernhard.
Afiliación
  • Caserta C; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Nucera S; Vita-Salute San Raffaele University, Milan, Italy.
  • Barcella M; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Fazio G; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
  • Naldini MM; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Pagani R; National Research Council, Institute for Biomedical Technologies, Segrate, Italy.
  • Pavesi F; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Desantis G; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Zonari E; Vita-Salute San Raffaele University, Milan, Italy.
  • D'Angiò M; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Capasso P; Vita-Salute San Raffaele University, Milan, Italy.
  • Lombardo A; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Milan, Italy.
  • Merelli I; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Spinelli O; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rambaldi A; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Ciceri F; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Silvestri D; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Valsecchi MG; Vita-Salute San Raffaele University, Milan, Italy.
  • Biondi A; National Research Council, Institute for Biomedical Technologies, Segrate, Italy.
  • Cazzaniga G; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Gentner B; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Leukemia ; 37(10): 1994-2005, 2023 10.
Article en En | MEDLINE | ID: mdl-37640845
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt / MicroARNs / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adult / Child / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt / MicroARNs / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adult / Child / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Italia